サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1396663

神経デバイスの世界市場

Neurology Devices: Global Markets

出版日
発行
BCC Research
ページ情報
英文 102 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.63円
神経デバイスの世界市場
出版日: 2023年12月11日
発行: BCC Research
ページ情報: 英文 102 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経デバイスの市場規模は、2023年の237億米ドルから、予測期間中は6.0%のCAGRで推移し、2028年には317億米ドルの規模に成長すると予測されています。

神経外科デバイスの部門が2023年の75億米ドルから、5.1%のCAGRで推移し、2028年には96億米ドルに達すると予測されています。また、神経血管デバイスの部門は2023年の59億米ドルから、8.7%のCAGRで推移し、2028年には89億米ドルに達すると予測されています。

当レポートでは、世界の神経デバイスの市場を調査し、市場の定義・背景・概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、技術動向、パイプライン分析、ESGの展開、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

  • 市場の見通し
  • 市場のハイライト

第3章 市場の背景・定義

  • 概要
  • 神経デバイス
  • 神経外科デバイス
  • 神経調節デバイス
  • 神経血管デバイス
  • 神経診断デバイス
  • 疾患の背景
  • 脳卒中
  • パーキンソン病
  • アルツハイマー病
  • てんかん・発作
  • 頸動脈疾患
  • 脳動脈瘤
  • 震え
  • 多発性硬化症
  • うつ

第4章 市場動向

  • 市場促進要因
  • 市場機会
  • 市場抑制要因

第5章 市場内訳：製品タイプ別

  • 概要
  • 神経外科デバイス
  • 神経調節デバイス
  • 神経血管デバイス
  • 神経診断デバイス

第6章 市場内訳：地域別

  • 概要
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • その他の地域

第7章 神経デバイス市場における新たな動向/技術

  • 概要
  • 神経学におけるAI
  • ウェアラブル神経デバイス
  • 神経内科における精密放射線治療
  • 定位放射線手術
  • 定位放射線治療
  • ブレインコンピューターインターフェイス (BCI)

第8章 神経デバイス市場の持続可能性：ESGの観点

  • 概要
  • ESG：イントロダクション
  • 環境要因
  • 社会的要因
  • ガバナンス的要因
  • 神経デバイス市場のESGパフォーマンス分析：企業別
  • 神経デバイス市場におけるESGに対する消費者の意識
  • 総論

第9章 パイプライン分析

  • 臨床試験のシナリオ

第10章 競合情勢

  • 業界シナリオ
  • 企業シェア

第11章 企業プロファイル

  • ABBOTT
  • AXONICS INC.
  • BOSTON SCIENTIFIC CORP.
  • B. BRAUN SE
  • DANAHER CORP.
  • ELEKTA
  • GE HEALTHCARE
  • INTEGRA LIFESCIENCES
  • JOHNSON & JOHNSON SERVICES INC.
  • KONINKLIJKE PHILIPS N.V.
  • LIVANOVA PLC
  • MEDTRONIC PLC
  • NATUS MEDICAL INC.
  • NEVRO CORP.
  • NIHON KOHDEN CORP.
  • PENUMBRA INC.
  • STRYKER CORP.
  • SIEMENS HEALTHCARE GMBH
  • TERUMO MEDICAL CORP.

第12章 付録：頭字語

図表

List of Tables

  • Summary Table : Global Market for Neurology Devices, by Product Type, Through 2028
  • Table 1 : Global Population, Aged 60 Years and Older, 2017-2050
  • Table 2 : Prevalent Cases of Brain and Central Nervous System Cancer, by Country, 2015-2030
  • Table 3 : Prevalent Cases of Parkinson's Disease, by Country, 2015-2030
  • Table 4 : Prevalent Cases of Ischemic Stroke, by Country, 2015-2030
  • Table 5 : Prevalent Cases of Idiopathic Epilepsy, by Country, 2015-2030
  • Table 6 : Prevalent Cases of Alzheimer's and Dementia, by Country, 2015-2030
  • Table 7 : Global Market for Neurology Devices, by Product Type, Through 2028
  • Table 8 : Global Market for Neurosurgical Devices, by Region, Through 2028
  • Table 9 : Global Market for Neuromodulation Devices, by Region, Through 2028
  • Table 10 : Global Market for Neurovascular Devices, by Region, Through 2028
  • Table 11 : Global Market for Neurodiagnostic Devices, by Region, Through 2028
  • Table 12 : Global Market for Neurology Devices, by Region, Through 2028
  • Table 13 : North American Market for Neurology Devices, by Country, Through 2028
  • Table 14 : Latin American Market for Neurology Devices, by Country, Through 2028
  • Table 15 : European Market for Neurology Devices, by Country, Through 2028
  • Table 16 : Asia-Pacific Market for Neurology Devices, by Country, Through 2028
  • Table 17 : RoW Market for Neurology Devices, Through 2028
  • Table 18 : Medtronic: ESG Performance
  • Table 19 : Medtronic: ESG Goals
  • Table 20 : Abbott: ESG Performance
  • Table 21 : Terumo: ESG Performance
  • Table 22 : Selected Neuromodulation Devices in Clinical Trials, as of 2023
  • Table 23 : Abbott: Neurostimulation Product Portfolio
  • Table 24 : Axonics Inc.: News, 2023
  • Table 25 : Axonics Inc.: Product Portfolio
  • Table 26 : Boston Scientific Corp.: News, 2023
  • Table 27 : Boston Scientific Corp.: Product Portfolio
  • Table 28 : B. Braun Se: Neurodevice Product Portfolio
  • Table 29 : Danaher Corp.: Company Financials, 2022
  • Table 30 : Danaher Corp.: Product Portfolio
  • Table 31 : Elekta: Product Portfolio
  • Table 32 : Natus Medical Inc.: Product Portfolio
  • Table 33 : Nihon Kohden Corp.: Product Portfolio
  • Table 34 : Penumbra Inc: Neurovascular Product Portfolio
  • Table 35 : Stryker: Business Segments
  • Table 36 : Siemens Healthineers: Product Portfolio
  • Table 37 : Acronyms Used in this Report

List of Figures

  • Summary Figure A : Global Market for Neurology Devices, by Product Type, 2020-2028
  • Summary Figure B : Global Market Shares of Neurology Devices, by Product Type, 2022
  • Figure 1 : Global Market for Neurology Devices, by Product Type, 2020-2028
  • Figure 2 : Global Market Shares of Neurology Devices, by Product Type, 2022
  • Figure 3 : Global Market for Neurosurgical Devices, by Region, 2020-2028
  • Figure 4 : Global Market for Neuromodulation Devices, by Region, 2020-2028
  • Figure 5 : Global Market for Neurovascular Devices, by Region, 2020-2028
  • Figure 6 : Global Market for Neurodiagnostic Devices, by Region, 2020-2028
  • Figure 7 : Global Market Shares of Neurology Devices, by Region, 2022
  • Figure 8 : North American Market Shares of Neurology Devices, by Country, 2022
  • Figure 9 : Latin American Market Shares of Neurology Devices, by Country, 2022
  • Figure 10 : European Market Shares of Neurology Devices, by Country, 2022
  • Figure 11 : Asia-Pacific Market Shares of Neurology Devices, by Country, 2022
  • Figure 12 : Emerging Trends and Technologies in the Neurology Devices Market
  • Figure 13 : Medtronic: Greenhouse Gas Emissions, 2020-2022
  • Figure 14 : Medtronic: Water Use, 2020-2022
  • Figure 15 : Medtronic: Total Waste Generated, 2020-2022
  • Figure 16 : Global Neurology Devices, Company Share, 2022
  • Figure 17 : Global Neurosurgical Devices, Company Share, 2022
  • Figure 18 : Global Neuromodulation Devices, Company Share, 2022
  • Figure 19 : Global Neurovascular Devices, Company Share, 2022
  • Figure 20 : Global Neurodiagnostic Devices, Company Share, 2022
  • Figure 21 : Abbott: Diagnostics Division, Net Revenue, 2020-2022
  • Figure 22 : Abbott: Market Share, by Business Segment, 2022
  • Figure 23 : Axonics Inc.: Net Revenue, 2020-2022
  • Figure 24 : Axonics Inc.: Market Share, by Business Segment, 2022
  • Figure 25 : Axonics Inc.: Sales Share, by Region, 2022
  • Figure 26 : Boston Scientific Corp.: Net Revenue, 2020-2022
  • Figure 27 : Boston Scientific Corp.: Market Share, by Business Segment, 2022
  • Figure 28 : B. Braun Se: Net Revenue, 2020-2022
  • Figure 29 : Danaher Corp.: Revenue Share, by Business Segment, 2022
  • Figure 30 : Danaher Corp.: Revenue Share, by Region, 2022
  • Figure 31 : Integra LifeSciences: Net Revenue, 2020-2022
  • Figure 32 : Integra LifeSciences: Market Share, by Business Segment, 2022
  • Figure 33 : LivaNova Plc: Neuromodulation Sales Share, by Region, 2022
  • Figure 34 : Nevro Corp.: Net Revenue, 2020-2022
  • Figure 35 : Nevro Corp.: Sales Share, by Region, 2022
  • Figure 36 : Penumbra: Net Revenue, 2020-2022
  • Figure 37 : Penumbra: Neuro Products Revenue, 2020-2022
  • Figure 38 : Stryker: Net Revenue, 2020-2022
  • Figure 39 : Stryker: Market Share, by Business Segment, 2022
  • Figure 40 : Siemens Healthineers: Net Revenue, 2020-2022
  • Figure 41 : Siemens Healthineers: Market Share, by Business Segment, 2022
目次
Product Code: MDS096A

Highlights:

The global market for neurology devices is estimated to increase from $23.7 billion in 2023 to reach $31.7 billion by 2028, at a compound annual growth rate (CAGR) of 6.0% from 2023 through 2028.

The global market for neurosurgical devices is estimated to increase from $7.5 billion in 2023 to reach $9.6 billion by 2028, at a compound annual growth rate (CAGR) of 5.1% from 2023 through 2028.

The global market for neurovascular devices is estimated to increase from $5.9 billion in 2023 to reach $8.9 billion by 2028, at a compound annual growth rate (CAGR) of 8.7% from 2023 through 2028.

Report Scope:

This report is a comprehensive study of the global market for neurology devices. It describes the neurology devices market and segments it by product type and region. Based on product type, the market is segmented into neurosurgical devices, neuromodulation devices, neurovascular devices and neurodiagnostic devices. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific and Rest of the World (RoW).

This report examines the factors driving growth in the neurology devices market, and it reviews major players, established companies, and new entrants.

In this report, the neurosurgical devices segment covers neurosurgical instruments, neurosurgery support devices/equipment, such as surgical microscopes, surgery navigation systems, and in the neurodiagnostic segment CT. MRI scanners are also considered as their role is prominent in the diagnosis of brain tumors and for radiosurgery applications. The revenue estimations are done for CT and MRI scans based on the neurology application point of view rather than the sales of the devices in this segment. The report does not cover neuro diagnostic assays, biomarker assays and related IVD instruments. It is purely focused on clinical applications, not research-oriented ones.

Report Includes:

  • 20 data tables and 18 additional tables
  • An overview of the global markets for neurology devices
  • In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
  • Evaluation of the current market size and revenue growth prospects specific to neurology devices, accompanied by a comprehensive market share analysis categorized by product type, and geographical region
  • Discussion on the emerging technologies in neurology devices market and areas of focus to forecast the market into various segments and sub-segments
  • Assessment of the key drivers and constraints that will shape the market for neurology devices and discussion on the upcoming market opportunities
  • Detailed description of the competitive landscape, product mapping, major player's strategic initiatives, R&D activities, and other initiatives
  • Detailed profiles of leading market participants, including Medtronic, Abbott, Terumo, Boston Scientific Corp., Natus Medical Inc., and Siemens Healthineers

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology
  • Information Sources
  • Primary Research
  • Secondary Research
  • Geographic Breakdown
  • Segmentation Breakdown

Chapter 2 Summary and Highlights

  • Market Outlook
  • Highlights of the Neurology Devices Market

Chapter 3 Market Background and Definitions

  • Overview
  • Neurology Devices
  • Neurosurgical Devices
  • Neuromodulation Devices
  • Neurovascular Devices
  • Neurodiagnostic Equipment
  • Diseases Background
  • Stroke
  • Parkinson's Disease
  • Alzheimer's Disease
  • Epilepsy and Seizures
  • Carotid Artery Disease
  • Cerebral Aneurysms
  • Tremors
  • Multiple Sclerosis
  • Depression

Chapter 4 Market Trends

  • Market Drivers
  • Aging Population
  • Neurology Disorders and Cancer Cases by Country
  • Penetration of Neurology Devices in Emerging Markets
  • Market Opportunity
  • Market Restraints

Chapter 5 Market Breakdown by Product Type

  • Overview
  • Neurosurgical Devices
  • Neuromodulation Devices
  • Neurovascular Devices
  • Neurodiagnostic Devices

Chapter 6 Market Breakdown by Region

  • Overview
  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 7 Emerging Trends/Technologies in the Neurology Devices Market

  • Overview
  • AI in Neurology
  • Wearable Neurology Devices
  • Precision Radiotherapy in Neurology
  • Stereotactic Radiosurgery
  • Stereotactic Body Radiation Therapy
  • Brain-Computer Interfaces (BCIs)

Chapter 8 Sustainability in Neurology Devices Market: An ESG Perspective

  • Overview
  • Introduction to ESG
  • Environmental Factors
  • Social Factors
  • Governance Factors
  • Neurology Devices Market ESG Performance Analysis by Company
  • Consumer Attitude Towards ESG in the Neurology Devices Market
  • Conclusion

Chapter 9 Pipeline Analysis

  • Clinical Trials Scenario

Chapter 10 Competitive Landscape

  • Industry Scenario
  • Company Shares

Chapter 11 Company Profiles

  • ABBOTT
  • AXONICS INC.
  • BOSTON SCIENTIFIC CORP.
  • B. BRAUN SE
  • DANAHER CORP.
  • ELEKTA
  • GE HEALTHCARE
  • INTEGRA LIFESCIENCES
  • JOHNSON & JOHNSON SERVICES INC.
  • KONINKLIJKE PHILIPS N.V.
  • LIVANOVA PLC
  • MEDTRONIC PLC
  • NATUS MEDICAL INC.
  • NEVRO CORP.
  • NIHON KOHDEN CORP.
  • PENUMBRA INC.
  • STRYKER CORP.
  • SIEMENS HEALTHCARE GMBH
  • TERUMO MEDICAL CORP.

Chapter 12 Appendix: Acronyms